Overall volumes in futures & options currently stand at 94.62 lakh contracts with a turnover of Rs. 6,40,559.64 crore.

Overall volumes in futures & options currently stand at 94.62 lakh contracts with a turnover of Rs. 6,40,559.64 crore.

In the coming session, bulls need to cross their immediate hurdle of 11,710, as sustaining above this level will likely open up further upmove towards its all-time high level of 11,760. But failure to cross and sustain above 11,710 level would lead  to consolidation and sideways movement where the levels of 11,640, followed by 11,550, are likely to act as support levels. Stocks in news: Dr Reddy’s Laboratories, Cipla, TCS, Prestige Estates Projects, Deepak Fertilisers and Petrochemicals Corporation, IndusInd Bank, Suven Life Sciences.

The outlook for the day is a soft start and the markets are expected to consolidate further during this truncated week. However, stock-specific volatility will continue as corporate earnings will continue to be on investors' radar. Wipro's results will be in focus today. At the time of writing, SGX Nifty was trading at 11,736.50 almost unchanged.

The private airline, Spicejet, announced on Monday that the company has started new international flights from Mumbai. New international schedule will commence from May-end, the company informed.

The shares of Rail Vikas Nikam Limited (RVNL) soared over 18 per cent in Monday’s trading session. The stock price has been moving northward since last three days.

Meghmani Organics spiked nearly 7 per cent as the company repaid term loan amounting to Rs 166.83 crore. With this repayment, the company is now having outstanding term loan of Rs 127 crore as on March 31, 2019.

As per IQVIA, the ophthalmic solution has a projected market size of US$76 million. Bimatoprost is used to treat high pressure inside the eye due to glaucoma (open-angle type) or other eye diseases.

India’s two largest IT service providers TCS and Infosys reported their last quarter numbers for FY19 on Friday. TCS’s management indicated that it will continue the growth trajectory in FY20E, despite macro challenges in the industry.

The unit is located in Southern India and has capacity of 2,00,000 MTPA. The consideration for acquisition would be Rs 70 crore, which would be funded through internal accruals.